Metraipolis › archive › dc_cc4980e237e3
Outcomes with frontline immune checkpoint inhibitors among individuals with BRAF-mutant non-small cell lung cancer — Europe PMC PMID:41450930
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41450930
- DOI
- 10.3389/fonc.2025.1681119
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T18:32:27.327Z
- SHA-256 of the archived text
9e469e07caa7da9149192891ca3f94c54a036a876ec0894eabbc8034d7c5c827- Stable URL of this page
https://metraipolis.com/documento/dc_cc4980e237e3
How to cite
Outcomes with frontline immune checkpoint inhibitors among individuals with BRAF-mutant non-small cell lung cancer — Europe PMC PMID:41450930 — Europe PMC (en), https://europepmc.org/article/MED/41450930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc4980e237e3 (Metraipolis archive dc_cc4980e237e3, sha256 9e469e07caa7da9149192891ca3f94c54a036a876ec0894eabbc8034d7c5c827)
BibTeX
@misc{dccc4980e237e3,
title = {Outcomes with frontline immune checkpoint inhibitors among individuals with BRAF-mutant non-small cell lung cancer — Europe PMC PMID:41450930},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41450930},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc4980e237e3; sha256 9e469e07caa7da9149192891ca3f94c54a036a876ec0894eabbc8034d7c5c827},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41450930. Agents can read the archived copy with the MCP tool read_document.